EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Endothelial-to-mesenchymal transition enhances permissiveness to AAV vectors in cardiac endothelial cells

Nina Volf, Roman Vuerich, Andrea Colliva, Maria Concetta Volpe, Margherita Marengon, Lorena Zentilin, Mauro Giacca, Nadja Anneliese Ruth Ring, Simone Vodret, Luca Braga, Serena Zacchigna

Molecular Therapy · 2024

DOI: 10.1016/j.ymthe.2024.08.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2024. Verfasst von Nina Volf und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Biology Laboratory, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy. Hauptthemen laut MEDLINE: Dependovirus, Genetic Vectors, Endothelial Cells, Transduction, Genetic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A major obstacle in inducing therapeutic angiogenesis in the heart is inefficient gene transfer to endothelial cells (ECs). Here, we identify compounds able to enhance the permissiveness of cardiac ECs to adeno-associated virus (AAV) vectors, which stand as ideal tools for in vivo gene delivery. We screened a library of >1,500 US Food and Drug Administration (FDA)-approved drugs, in combination with AAV vectors, in cardiac ECs. Among the top drugs increasing AAV-mediated transduction, we found vatalanib, an inhibitor of multiple tyrosine kinase receptors. The increased AAV transduction efficiency by vatalanib was paralleled by induction of the endothelial-to-mesenchymal transition, as documented by decreased endothelial and increased mesenchymal marker expression. Induction of the endothelial-to-mesenchymal transition by other strategies similarly increased EC permissiveness to AAV vectors. In vivo injection of AAV vectors in the heart after myocardial infarction resulted in the selective transduction of cells undergoing the endothelial-to-mesenchymal transition, which is known to happen transiently after cardiac ischemia. Collectively, these results point to the endothelial-to-mesenchymal transition as a mechanism for improving AAV transduction in cardiac ECs, with implications for both basic research and the induction of therapeutic angiogenesis in the heart.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusGenetic VectorsEndothelial CellsTransduction, GeneticAnimalsHumansMiceEpithelial-Mesenchymal TransitionMyocardial InfarctionGenetic TherapyGene Transfer TechniquesMyocardium

Stichwörter der Autor:innen

adeno-associated viral vectorscardiovascular biologyendothelial cellsendothelial-to-mesenchymal transitiongene therapyhigh-throughput screening

Autor:innen und Institutionen

  • Cardiovascular Biology Laboratory, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
  • Cardiovascular Biology Laboratory, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy; Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
  • Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy; Functional Biology Laboratory, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
  • Molecular Medicine Laboratory, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
  • Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy; Molecular Medicine Laboratory, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
  • Functional Biology Laboratory, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.

Förderung

  • European Union

Zitieren

APA

Volf, N., Vuerich, R., Colliva, A., Volpe, M. C., Marengon, M., Zentilin, L., Giacca, M., Ring, N. A. R., Vodret, S., Braga, L., & Zacchigna, S. (2024). Endothelial-to-mesenchymal transition enhances permissiveness to AAV vectors in cardiac endothelial cells. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2024.08.014

Vancouver

Volf N, Vuerich R, Colliva A, Volpe MC, Marengon M, Zentilin L, et al. Endothelial-to-mesenchymal transition enhances permissiveness to AAV vectors in cardiac endothelial cells. Molecular Therapy. 2024. doi:10.1016/j.ymthe.2024.08.014

BibTeX
@article{Volf2024,
  author = {Volf, Nina and Vuerich, Roman and Colliva, Andrea and Volpe, Maria Concetta and Marengon, Margherita and Zentilin, Lorena and Giacca, Mauro and Ring, Nadja Anneliese Ruth and Vodret, Simone and Braga, Luca and Zacchigna, Serena},
  title = {Endothelial-to-mesenchymal transition enhances permissiveness to AAV vectors in cardiac endothelial cells},
  journal = {Molecular Therapy},
  year = {2024},
  doi = {10.1016/j.ymthe.2024.08.014}
}
Kostenlos starten →